BlackHorse Capital Discloses 5.5% Stake in Cypress Bioscience (CYPB)

In a 13D filing after the close Friday on Cypress Bioscience Inc. (Nasdaq: CYPB), BlackHorse Capital disclosed a 5.5% stake (2,043,872 shares) in the company.

In a pretty standard disclosure, the firm did not make any direct requests on the company, but said they will review its investment on a continuing basis and may to engage in discussions with management or the Board of Directors concerning the business and future plans of the company.

Cypress is committed to being an innovator and leader in providing products for the treatment of patients with Fibromyalgia Syndrome.